253 related articles for article (PubMed ID: 20448018)
1. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
van Timmeren MM; van der Veen BS; Stegeman CA; Petersen AH; Hellmark T; Collin M; Heeringa P
J Am Soc Nephrol; 2010 Jul; 21(7):1103-14. PubMed ID: 20448018
[TBL] [Abstract][Full Text] [Related]
2. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
Franssen CF; Huitema MG; Muller Kobold AC; Oost-Kort WW; Limburg PC; Tiebosch A; Stegeman CA; Kallenberg CG; Tervaert JW
J Am Soc Nephrol; 1999 Jul; 10(7):1506-15. PubMed ID: 10405206
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis.
Schreiber A; Pham CT; Hu Y; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2012 Mar; 23(3):470-82. PubMed ID: 22241891
[TBL] [Abstract][Full Text] [Related]
4. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis.
van der Veen BS; Petersen AH; Belperio JA; Satchell SC; Mathieson PW; Molema G; Heeringa P
Clin Exp Immunol; 2009 Oct; 158(1):143-53. PubMed ID: 19737241
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
8. Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo.
van der Veen BS; Chen M; Müller R; van Timmeren MM; Petersen AH; Lee PA; Satchell SC; Mathieson PW; Saleem MA; Stegeman CA; Zwerina J; Molema G; Heeringa P
Ann Rheum Dis; 2011 Feb; 70(2):356-65. PubMed ID: 21062851
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis.
Bontscho J; Schreiber A; Manz RA; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2011 Feb; 22(2):336-48. PubMed ID: 21233415
[TBL] [Abstract][Full Text] [Related]
10. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.
Xiao H; Heeringa P; Liu Z; Huugen D; Hu P; Maeda N; Falk RJ; Jennette JC
Am J Pathol; 2005 Jul; 167(1):39-45. PubMed ID: 15972950
[TBL] [Abstract][Full Text] [Related]
11. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
Xiao H; Heeringa P; Hu P; Liu Z; Zhao M; Aratani Y; Maeda N; Falk RJ; Jennette JC
J Clin Invest; 2002 Oct; 110(7):955-63. PubMed ID: 12370273
[TBL] [Abstract][Full Text] [Related]
13. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
Huugen D; Xiao H; van Esch A; Falk RJ; Peutz-Kootstra CJ; Buurman WA; Tervaert JW; Jennette JC; Heeringa P
Am J Pathol; 2005 Jul; 167(1):47-58. PubMed ID: 15972951
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
Lardinois OM; Deterding LJ; Hess JJ; Poulton CJ; Henderson CD; Jennette JC; Nachman PH; Falk RJ
PLoS One; 2019; 14(2):e0213215. PubMed ID: 30818380
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
Xiao H; Ciavatta D; Aylor DL; Hu P; de Villena FP; Falk RJ; Jennette JC
Am J Pathol; 2013 Apr; 182(4):1219-26. PubMed ID: 23384999
[TBL] [Abstract][Full Text] [Related]
16. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
Boomsma MM; Stegeman CA; Oost-Kort WW; Kallenberg CG; Moguilevsky N; Limburg PC; Tervaert JW
J Immunol Methods; 2001 Aug; 254(1-2):47-58. PubMed ID: 11406152
[TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
18. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
20. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?
Lood C; Allhorn M; Lood R; Gullstrand B; Olin AI; Rönnblom L; Truedsson L; Collin M; Bengtsson AA
Arthritis Rheum; 2012 Aug; 64(8):2698-706. PubMed ID: 22392566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
